Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Research Group

Cancer Biomarkers

Expiration Date

Wed, October 2, 2024: 12:00p.m. UTC

Program Official

Type of Funding Opportunity

RFA

Clinical Trials Status

Clinical Trial Not Allowed

Announcement Number And URL

Activity Code

R33